Kura Oncology grants 133,750 inducement stock options priced at $8.77 per share
PUBT · 05/04 11:31
Share
Listen to the news
- Kura Oncology granted nonstatutory stock options covering 133,750 common shares to five new employees on May 1, 2026 under its 2023 Inducement Option Plan, as amended.
- Exercise price set at USD 8.77 per share, matching closing price on May 1.
- Awards vest over four years, with 25% vesting on one-year anniversary of vesting start date.
- Remaining shares vest monthly over following 36 months, contingent on continued service.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202605040730PRIMZONEFULLFEED9711811) on May 04, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved